Gnrh agonist
Gnrh agonist has been studied in 2 papers since 2024: none in people yet, 1 in animals, 1 review; 1 in the past year. The research so far is in animals. The newest paper, Sep 30, 2026: “Bone Health in Transgender Individuals: A Narrative Review on the Impact of Gender-Affirming Hormone Therapy”.
2 papers study it1 findingUpdated
See all 2 papers on gnrh agonist
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Animals1
What did studies of gnrh agonist find?
1Studies of gnrh agonist measured one outcome, cortisol.
Cortisol
downin mice1
1 study
Cortisol
downin mice1
Gnrh agonist decreases cortisol in mice (ovariectomy-induced elevation of cortisol).
“the administration of GnRHa suppressed the increase in FSH levels and the elevation of cortisol”
Animalsovariectomy-induced elevation of cortisolfemales
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association